Blackhill Capital Inc Bristol Myers Squibb CO Transaction History

Blackhill Capital Inc

$1.61 Billion
Q2 2024

A detailed history of Blackhill Capital Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blackhill Capital Inc holds 214,464 shares of BMY stock, worth $10.9 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

214,464

Previous 314,464 31.8%

Holding current value

$10.9 Million

Previous $17.1 Million 47.77%

% of portfolio

0.55%

Previous 0.98%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $4.03 Million - $5.3 Million	-100,000 Reduced 31.8%	214,464 $8.91 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $2.73 Million - $3.09 Million	-56,800 Reduced 15.3%	314,464 $17.1 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $1.39 Million - $1.65 Million	-28,600 Reduced 7.15%	371,264 $19 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $602,056 - $673,192	-10,400 Reduced 2.53%	399,864 $23.2 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $1.72 Million - $1.91 Million	-27,000 Reduced 6.17%	410,264 $26.2 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $236,555 - $268,308	-3,600 Reduced 0.82%	437,264 $30.3 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $1.63 Million - $1.93 Million	23,800 Added 5.71%	440,864 $31.7 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $1,573 - $929,764	-12,100 Reduced 2.82%	417,064 $29.6 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $116,192 - $127,968	-1,600 Reduced 0.37%	429,164 $33 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $203,794 - $237,576	3,800 Added 0.89%	430,764 $26.9 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $118,680 - $133,480	-2,000 Reduced 0.47%	426,964 $27 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $46,192 - $52,344	800 Added 0.19%	428,964 $26.6 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $172,290 - $190,920	3,000 Added 0.71%	428,164 $25.8 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $98,676 - $115,362	-1,800 Reduced 0.42%	425,164 $25 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $92,800 - $134,860	-2,000 Reduced 0.47%	426,964 $23.8 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $1.52 Million - $1.98 Million	30,800 Added 7.74%	428,964 $27.5 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $2.11 Million - $2.5 Million	-49,381 Reduced 11.03%	398,164 $20.2 Million
Q2 2019 Jul 29, 2019	BUY	$44.62 - $49.34 $954,868 - $1.06 Million	21,400 Added 5.02%	447,545 $20.3 Million
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $410,592 - $489,580	-9,100 Reduced 2.09%	426,145 $20.3 Million
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $82,892 - $107,491	-1,700 Reduced 0.39%	435,245 $22.6 Million
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $720,052 - $897,465	-14,250 Reduced 3.16%	436,945 $24.2 Million
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $898,800 - $1.03 Million	-15,000 Reduced 3.22%	451,195 $28.5 Million
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $25.7 Million - $29.7 Million	466,195	466,195 $29.7 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhill Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackhill Capital Inc with notifications on news.

Account

Blackhill Capital Inc Bristol Myers Squibb CO Transaction History